This guideline provides clinical practice guidance for treating diabetes in older adults, particularly those over the age of 65, as type 2 diabetes is becoming more prevalent in this age group. Aging exacerbates the metabolic effects of diabetes, accelerating the progression of complications. The guidelines aim to present evidence, primarily from controlled trials, on therapeutic options and their outcomes for this population, with a focus on avoiding unnecessary or harmful side effects. The goal is to offer healthcare providers strategies that will benefit older adults with diabetes, addressing both type 1 and type 2, while considering the impact of aging on their overall health.

A survey of older adults with diabetes revealed a wide variety of health conditions that affect their quality of life, with many participants reporting multiple comorbidities. About 40% of respondents ranked diabetes as their most important health concern, but other conditions like hypertension, heart disease, and depression were also significant. The survey results highlight the importance of tailoring treatment based on an individual’s health status and cognitive function, with some participants indicating that diabetes did not dominate their health concerns. The findings emphasize the need for clear communication between clinicians and patients regarding the risks and benefits of different therapeutic strategies.

Reference: LeRoith D, Biessels GJ, Braithwaite SS, et al. Treatment of Diabetes in Older Adults: An Endocrine Society* Clinical Practice Guideline. J Clin Endocrinol Metab. 2019;104(5):1520-1574. doi: 10.1210/jc.2019-00198.